Magnesium as a Mediator of Bone and Vitamin D Metabolism in Patients on Antiepileptic Drug Therapy
Sponsor: Drexel University
Terminated
Closure of Drexel University Hahnemann Hospital where Referring Physician Worked
Other terminated trials from Drexel University
A observational or N/A phase clinical study on Epilepsy and Magnesium Deficiency, this trial is terminated or withdrawn. The trial is conducted by Drexel University and has accumulated 11 data snapshots since 2015. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
11 versions recorded-
Sep 2024 — Present [monthly]
Terminated
-
Jul 2024 — Sep 2024 [monthly]
Terminated
-
Dec 2021 — Jul 2024 [monthly]
Terminated
-
Mar 2021 — Dec 2021 [monthly]
Terminated
Status: Unknown Status → Terminated
-
Jan 2021 — Mar 2021 [monthly]
Unknown Status
▶ Show 6 earlier versions
-
Nov 2020 — Jan 2021 [monthly]
Unknown Status
-
Sep 2020 — Nov 2020 [monthly]
Unknown Status
Status: Recruiting → Unknown Status
-
Sep 2018 — Sep 2020 [monthly]
Recruiting
-
Jun 2018 — Sep 2018 [monthly]
Recruiting
-
May 2018 — Jun 2018 [monthly]
Recruiting
-
Apr 2018 — May 2018 [monthly]
Recruiting
First recorded
Aug 2015
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Drexel University
For direct contact, visit the study record on ClinicalTrials.gov .